N-{'4-substituted piperazine1-sulfonylmethyl!alkyl}-N-hydroxyfoma mide compounds as metalloproteinase inhibitors

Details for Australian Patent Application No. 2004251104 (hide)

Owner AstraZeneca AB

Inventors Waterson, David; Finlay, Maurice Raymond Verschoyle

Agent Freehills

Pub. Number AU-B-2004251104

PCT Pub. Number WO2005/000822

Priority 0301922-1 27.06.03 SE

Filing date 23 June 2004

Wipo publication date 6 January 2005

Acceptance publication date 8 May 2008

International Classifications

A61P 11/00 (2006.01) Drugs for disorders of the respiratory system

A61P 19/02 (2006.01) Drugs for skeletal disorders

C07D 239/46 (2006.01) Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings

C07D 295/26 (2006.01) Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms

C07D 309/04 (2006.01) Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings

C07D 401/12 (2006.01) Heterocyclic compounds containing two or more hetero rings

C07D 405/12 (2006.01) Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom

Event Publications

5 January 2006 PCT application entered the National Phase

  PCT publication WO2005/000822 Priority application(s): WO2005/000822

8 May 2008 Application Accepted

  Published as AU-B-2004251104

4 September 2008 Standard Patent Sealed

20 January 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004251105-Reagents and methods for the formation of disulfide bonds and the glycosylation of proteins

2004251103-Cytotoxic depsipeptides